| [1] |
Sánchez-Fueyo A, Whitehouse G, Grageda N, et al. Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation[J]. Am J Transplant, 2020, 20(4):1125-1136.
|
| [2] |
Tang Q, Vincenti F. Transplant trials with Tregs: perils and promises[J]. J Clin Invest, 2017, 127(7):2505-2512.
|
| [3] |
Chen L, Huang H, Zhang W, et al. Exosomes derived fromT regulatory cells suppress CD8+ cytotoxic T lymphocyte proliferation and prolong liver allograft survival[J]. Med Sci Monit, 2019(25): 4877-4884.
|
| [4] |
He Q, Fan H, Li JQ, et al. Decreased circulating CD4+CD25highFoxp3+ T cells during acute rejection in liver transplant patients[J]. Transplant Proc, 2011, 43(5):1696-1700.
|
| [5] |
Ma B, Yang JY, Song WJ, et al. Combining exosomes derived from immature DCs with donor antigen-specific Treg cells induces tolerance in a rat liver allograft model[J]. Sci Rep, 2016(6):32971.
|
| [6] |
Brinke AT, Martinez-Llordella M, Cools N, et al. Ways forward for tolerance-inducing cellular therapies-an AFACTT perspective[J]. Front Immunol, 2019(10):181.
|
| [7] |
Zhang Y, Zhao H, Bo L, et al. Total body irradiation of donors can alter the course of tolerance and induce acute rejection ina spontaneous tolerance rat liver transplantation model[J]. Sci China Life Sci, 2012, 55(9):774-781.
|
| [8] |
Tang J, Yang R, Lv L, et al. Transforming growth factor-beta-expressing mesenchymal stem cells induce local tolerance in a rat liver transplantation model of acute rejection[J]. Stem Cells, 2016, 34(11):2681-2692.
|
| [9] |
Todo S, Yamashita K, Goto R, et al. A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation[J]. Hepatology, 2016, 64(2):632-643.
|
| [10] |
Todo S, Yamashita K. Anti-donor regulatory T cell therapy in liver transplantation[J]. Hum Immunol, 2018, 79(5):288-293.
|
| [11] |
Gupta PK, Mcintosh CM, Chong AS, et al. The pursuit of transplantation tolerance: new mechanistic insights[J]. Cell Mol Immunol, 2019, 16(4):324-333.
|
| [12] |
DuPage M, Bluestone JA. Harnessing the plasticity of CD4(+) T cells to treat immune-mediated disease[J]. Nat Rev Immunol, 2016, 16(3):149-163.
|
| [13] |
Noyan F, Zimmermann K, Hardtke-Wolenski M, et al. Prevention of allograft rejection by use of regulatory T cells with an MHC-specific chimeric antigen receptor[J]. Am J Transplant, 2017, 17(4):917-930.
|
| [14] |
Benítez C, Londoño MC, Miquel R, et al. Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients[J]. Hepatology, 2013, 58(5):1824-1835.
|
| [15] |
Nafady-Hego H, Li Y, Ohe H, et al. Utility of CD127 combined with FOXP3 for identification of operational tolerance after liver transplantation[J]. Transpl Immunol, 2016(36):1-8.
|
| [16] |
Wang K, Song ZL, Wu B, et al. The T-helper cells 17 instead of Tregs play the key role in acute rejection after pediatric liver transplantation[J]. Pediatr Transplant, 2019, 23(3):e13363.
|
| [17] |
李瑞东，陶一峰，沈从欢, 等. Th17、Treg及其平衡与大鼠肝移植术后免疫耐受的研究[J]. 世界华人消化杂志, 2017, 25(34):3046-3052.
|
| [18] |
Jhun J, Lee SH, Lee SK, et al. Serial monitoring of immune markers being represented regulatory T cell/T helper 17 cell ratio: indicating tolerance for tapering immunosuppression after liver transplantation[J]. Front Immunol, 2018(9):352.
|
| [19] |
Haarer J, Riquelme P, Hoffmann P, et al. Early enrichment and restitution of the peripheral blood Treg pool is associated with rejection-free stable immunosuppression after liver transplantation[J]. Transplantation, 2016, 100(7):e39-40.
|
| [20] |
Han JW, Joo DJ, Kim JH, et al. Early reduction of regulatory T cells is associated with acute rejection in liver transplantation under tacrolimus-based immunosuppression with basiliximab induction[J]. Am J Transplant, 2020, 20(8):2058-2069.
|